MedTrace Logo

Neural Stem Cells Therapy for Cerebral Palsy

NCT03005249 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-08-29

No results posted yet for this study

Summary

To evaluate the safety and efficacy of neural stem cells (NSCs) therapy for cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

PROCEDURE

neural stem cells therapy group

The patients will be assigned to neural stem cells therapy group for cerebral palsy.

OTHER

the control group

The patients will be assigned to the control group for cerebral palsy.

Sponsors & Collaborators

  • The First Affiliated Hospital of Dalian Medical University

    lead OTHER

Principal Investigators

  • Jing Liu, Ph.D · The First Affiliated Hospital of Dalian Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-09-30
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03005249 on ClinicalTrials.gov